Arrakis Therapeutics
Waltham
About Arrakis Therapeutics
Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $113.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2019)
- Website: arrakistx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/arrakis-therapeutics-50457 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.